Clinical Trials Browser

Phase 1 × BID protein, human × Lymphoid × Clear all

NCT01433731 2016-03-24

Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)

Phase 1 Completed

18 enrolled 7 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous